Ariel F. Martinez

Ariel F. Martinez

Auto-generated profile, based on publicly available information

Ariel F. Martinez

Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2019 in Genetics in Medicine
Verified
Journal Article
Closed access
KWKarin Weiss
Karin Weiss
HLHayley P. Lazar
Hayley P. Lazar
AKAlina Kurolap
Alina Kurolap
AMAriel F. Martinez
Ariel F. Martinez
TPTamar Paperna
Tamar Paperna
KLKatherine Lachlan
Katherine Lachlan

29 January 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MAMauricio Arcos-Burgos
Mauricio Arcos-Burgos
Jorge I. VélezJorge I. Vélez
Jorge I. Vélez
AMAriel F. Martinez
Ariel F. Martinez
MRMarta Ribasés
Marta Ribasés
JRJosep A. Ramos-Quiroga
Josep A. Ramos-Quiroga
MMMaximilian Muenke
Maximilian Muenke
Genetic factors are strongly implicated in the susceptibility to develop externalizing syndromes such as attention-deficit/hyperactivity disorder (ADHD), oppositional defiant disorder, conduct disorder, and substance use disorder (SUD). Variants in the ADGRL3 (LPHN3) gene predispose to ADHD and predict ADHD severity, disruptive behaviors comorbidity, long-term outcome, and response to treatment. In this study, we investigated whether variants within ADGRL3 are associated with SUD, a disorder that is frequently co-morbid with ADHD. Using family-based, case-control, and longitudinal samples from disparate regions of the world (n = 2698), recruited either for clinical, genetic epidemiological or pharmacogenomic studies of ADHD, we assembled recursive-partitioning frameworks (classification tree analyses) with clinical, demographic, and ADGRL3 genetic information to predict SUD susceptibility. Our results indicate that SUD can be efficiently and robustly predicted in ADHD participants. The genetic models used remained highly efficient in predicting SUD in a large sample of individuals with severe SUD from a psychiatric institution that were not ascertained on the basis of ADHD diagnosis, thus identifying ADGRL3 as a risk gene for SUD. Recursive-partitioning analyses revealed that rs4860437 was the predominant predictive variant. This new methodological approach offers novel insights into higher order predictive interactions and offers a unique opportunity for translational application in the clinical assessment of patients at high risk for SUD.

1 October 2017 in Journal of Hepatology
Verified
Journal Article
Closed access
MGMaria J. Guillen-Sacoto
Maria J. Guillen-Sacoto
AMAriel F. Martinez
Ariel F. Martinez
YAYu Abe
Yu Abe
PKPaul Kruszka
Paul Kruszka
KWKarin Weiss
Karin Weiss
MMMaximilian Muenke
Maximilian Muenke

17 May 2018 in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Verified
Journal Article
Closed access
PDF file
PKPaul Kruszka
Paul Kruszka
AMAriel F. Martinez
Ariel F. Martinez
MMMaximilian Muenke
Maximilian Muenke

15 January 2021 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
PDF file
EEEkanem N. Ekure
Ekanem N. Ekure
AAAdebowale Adeyemo
Adebowale Adeyemo
HLHanhan Liu
Hanhan Liu
OSOgochukwu Sokunbi
Ogochukwu Sokunbi
NKNnenna Kalu
Nnenna Kalu
PKPaul Kruszka
Paul Kruszka
Background: Congenital heart disease (CHD) is the most common birth defect and affects roughly 1% of the global population. There have been many large CHD sequencing projects in developing countries but none in sub-Saharan Africa. In this exome sequencing study, we recruited families from Lagos, Nigeria, affected by structural heart disease. Methods: Ninety-eight participants with CHD and an average age of 3.6 years were recruited from Lagos, Nigeria. Exome sequencing was performed on probands and parents when available. For genes of high interest, we conducted functional studies in Drosophila using a cardiac-specific RNA interference–based gene silencing system. Results: The 3 most common CHDs were tetralogy of Fallot (20%), isolated ventricular septal defect (14%), and transposition of the great arteries (8%). Ten percent of the cohort had pathogenic or likely pathogenic variants in genes known to cause CHD. In 64 complete trios, we found 34 de novo variants that were not present in the African population in the Genome Aggregation Database (v3). Nineteen loss of function variants were identified using the genome-wide distribution of selection effects for heterozygous protein-truncating variants (s het ). Nine genes caused a significant mortality when silenced in the Drosophila heart, including 4 novel disease genes not previously associated with CHD ( UBB, EIF4G3, SREBF1 , and METTL23 ). Conclusions: This study identifies novel candidate genes and variants for CHD and facilitates comparisons with previous CHD sequencing studies in predominantly European cohorts. The study represents an important first step in genomic studies of CHD in understudied populations. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01952171.

13 July 2020 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MHMarcela Henriquez-Henriquez
Marcela Henriquez-Henriquez
MAMaria T. Acosta
Maria T. Acosta
AMAriel F. Martinez
Ariel F. Martinez
Jorge I. VélezJorge I. Vélez
Jorge I. Vélez
FLFrancisco Lopera
Francisco Lopera
MMMaximilian Muenke
Maximilian Muenke
Attention deficit hyperactivity disorder (ADHD) is the most prevalent neurodevelopmental disorder in children, with genetic factors accounting for 75–80% of the phenotypic variance. Recent studies have suggested that ADHD patients might present with atypical central myelination that can persist into adulthood. Given the essential role of sphingolipids in myelin formation and maintenance, we explored genetic variation in sphingolipid metabolism genes for association with ADHD risk. Whole-exome genotyping was performed in three independent cohorts from disparate regions of the world, for a total of 1520 genotyped subjects. Cohort 1 (MTA (Multimodal Treatment study of children with ADHD) sample, 371 subjects) was analyzed as the discovery cohort, while cohorts 2 (Paisa sample, 298 subjects) and 3 (US sample, 851 subjects) were used for replication. A set of 58 genes was manually curated based on their roles in sphingolipid metabolism. A targeted exploration for association between ADHD and 137 markers encoding for common and rare potentially functional allelic variants in this set of genes was performed in the screening cohort. Single- and multi-locus additive, dominant and recessive linear mixed-effect models were used. During discovery, we found statistically significant associations between ADHD and variants in eight genes (GALC,CERS6,SMPD1,SMPDL3B,CERS2,FADS3,ELOVL5, andCERK). Successful local replication for associations with variants inGALC,SMPD1, andCERS6was demonstrated in both replication cohorts. Variants rs35785620, rs143078230, rs398607, and rs1805078, associated with ADHD in the discovery or replication cohorts, correspond to missense mutations with predicted deleterious effects. Expression quantitative trait loci analysis revealed an association between rs398607 and increasedGALCexpression in the cerebellum.